ALYATEC contributed to a research study led by Dr. Vriginie Doyen (CHU UCL Namur – Université Catholique de Louvain) in which were also involved the University Hospital of Strasbourg, the University of Technology of Troyes and the University of Strasbourg.
The objective was to evaluate the early and late asthmatic responses of patients exposed to house dust mites allergens in the ALYATEC exposure chamber.
The collaboration resulted in a publication in the scientific journal Allergy in February 2023:
Doyen et al (2023) – Induction of immunosuppressive CD39 but not the trafficking C-C chemokine receptor 4 on Treg during LAR in mite allergic asthma (link to the article)
